文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

预测治疗和出院后一年内慢性阻塞性肺疾病急性加重患者的再入院率。

Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge.

机构信息

Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, Jiangjiayuan 121#, Gulou District, Nanjing, 210000, Jiangsu, China.

出版信息

BMC Pulm Med. 2021 Oct 15;21(1):320. doi: 10.1186/s12890-021-01692-3.


DOI:10.1186/s12890-021-01692-3
PMID:34654406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8518323/
Abstract

BACKGROUND: To investigate the risk factors and construct a logistic model and an extreme gradient boosting (XGBoost) model to compare the predictive performances for readmission in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients within one year. METHODS: In total, 636 patients with AECOPD were recruited and divided into readmission group (n = 449) and non-readmission group (n = 187). Backward stepwise regression method was used to analyze the risk factors for readmission. Data were divided into training set and testing set at a ratio of 7:3. Variables with statistical significance were included in the logistic model and variables with P < 0.1 were included in the XGBoost model, and receiver operator characteristic (ROC) curves were plotted. RESULTS: Patients with acute exacerbations within the previous 1 year [odds ratio (OR) = 4.086, 95% confidence interval (CI) 2.723-6.133, P < 0.001), long-acting β agonist (LABA) application (OR = 4.550, 95% CI 1.587-13.042, P = 0.005), inhaled corticosteroids (ICS) application (OR = 0.227, 95% CI 0.076-0.672, P = 0.007), glutamic-pyruvic transaminase (ALT) level (OR = 0.985, 95% CI 0.971-0.999, P = 0.042), and total CAT score (OR = 1.091, 95% CI 1.048-1.136, P < 0.001) were associated with the risk of readmission. The AUC value of the logistic model was 0.743 (95% CI 0.692-0.795) in the training set and 0.699 (95% CI 0.617-0.780) in the testing set. The AUC value of XGBoost model was 0.814 (95% CI 0.812-0.815) in the training set and 0.722 (95% CI 0.720-0.725) in the testing set. CONCLUSIONS: The XGBoost model showed a better predictive value in predicting the risk of readmission within one year in the AECOPD patients than the logistic regression model. The findings of our study might help identify patients with a high risk of readmission within one year and provide timely treatment to prevent the reoccurrence of AECOPD.

摘要

背景:本研究旨在探讨慢性阻塞性肺疾病急性加重(AECOPD)患者在一年内再次入院的风险因素,并构建逻辑回归(logistic)模型和极端梯度提升(XGBoost)模型来比较预测性能。

方法:共纳入 636 例 AECOPD 患者,根据是否在 1 年内再次入院分为再入院组(n=449)和非再入院组(n=187)。采用后退逐步回归方法分析再入院的风险因素。将数据分为训练集和测试集,比例为 7:3。将有统计学意义的变量纳入逻辑回归模型,将 P<0.1 的变量纳入 XGBoost 模型,并绘制受试者工作特征(ROC)曲线。

结果:在过去 1 年内急性加重的患者(比值比[OR] = 4.086,95%置信区间[CI] 2.723-6.133,P<0.001)、长效β受体激动剂(LABA)应用(OR = 4.550,95% CI 1.587-13.042,P=0.005)、吸入性糖皮质激素(ICS)应用(OR = 0.227,95% CI 0.076-0.672,P=0.007)、谷草转氨酶(ALT)水平(OR = 0.985,95% CI 0.971-0.999,P=0.042)和总 CAT 评分(OR = 1.091,95% CI 1.048-1.136,P<0.001)与再入院风险相关。逻辑回归模型在训练集的 AUC 值为 0.743(95% CI 0.692-0.795),在测试集的 AUC 值为 0.699(95% CI 0.617-0.780)。XGBoost 模型在训练集的 AUC 值为 0.814(95% CI 0.812-0.815),在测试集的 AUC 值为 0.722(95% CI 0.720-0.725)。

结论:与逻辑回归模型相比,XGBoost 模型在预测 AECOPD 患者一年内再入院风险方面具有更好的预测价值。本研究的结果可能有助于识别出一年内有高再入院风险的患者,并及时进行治疗,以防止 AECOPD 的再次发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/8518323/78d1b37f3435/12890_2021_1692_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/8518323/241c2a0d069b/12890_2021_1692_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/8518323/a5dd0dc164c0/12890_2021_1692_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/8518323/656c17d8a6e9/12890_2021_1692_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/8518323/78d1b37f3435/12890_2021_1692_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/8518323/241c2a0d069b/12890_2021_1692_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/8518323/a5dd0dc164c0/12890_2021_1692_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/8518323/656c17d8a6e9/12890_2021_1692_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/8518323/78d1b37f3435/12890_2021_1692_Fig4_HTML.jpg

相似文献

[1]
Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge.

BMC Pulm Med. 2021-10-15

[2]
[Correlation between serum nitric oxide synthase levels and readmission due to acute exacerbation within 30 days in patients with acute exacerbations of chronic obstructive pulmonary disease].

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024-7

[3]
Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Int J Chron Obstruct Pulmon Dis. 2023

[4]
[Comparison of the predictive performance of Logistic regression, BP neural network and support vector machine model for the risk of acute exacerbation of readmission in elderly patients with chronic obstructive pulmonary disease within 30 days].

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022-8

[5]
Risk factors associated with chronic obstructive pulmonary disease early readmission.

Curr Med Res Opin. 2014-2

[6]
Frailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: a longitudinal study.

Ther Adv Respir Dis. 2017-8-29

[7]
[Construction and verification of the risk prediction model for acute exacerbation within 6 months in patients with chronic obstructive pulmonary disease: a secondary analysis based on previous research data].

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022-4

[8]
[Establishment and verification of risk prediction model of acute exacerbation of chronic obstructive pulmonary disease based on regression analysis].

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021-1

[9]
Systemic Inflammatory Marker CRP Was Better Predictor of Readmission for AECOPD Than Sputum Inflammatory Markers.

Arch Bronconeumol. 2016-3

[10]
Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease.

Int J Chron Obstruct Pulmon Dis. 2015-7-2

引用本文的文献

[1]
Anemia and polycythemia in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease: prevalence, patient characteristics, and risk of readmission and mortality.

Eur Clin Respir J. 2025-8-23

[2]
Development and validation of a nomogram model for predicting one-year unplanned readmission in patients with chronic obstructive pulmonary disease.

Eur J Med Res. 2025-8-2

[3]
Prognostic risk prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a systematic review and meta-analysis.

Respir Res. 2024-11-14

[4]
A systematic review and meta-analysis of chronic obstructive pulmonary disease in asia: risk factors for readmission and readmission rate.

BMC Pulm Med. 2024-8-12

[5]
Predicting Hospital Readmission in Medicaid Patients With COPD Using Administrative and Claims Data.

Respir Care. 2024-4-22

[6]
Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) - A Systematic Review.

Int J Chron Obstruct Pulmon Dis. 2023-11-18

[7]
Is the incident of once chronic obstructive pulmonary disease related admission a high risk for readmission in the future?

J Thorac Dis. 2023-6-30

[8]
A Nomogram for Predicting Cardiovascular Diseases in Chronic Obstructive Pulmonary Disease Patients.

J Healthc Eng. 2022

[9]
Characteristics of Artificial Intelligence Clinical Trials in the Field of Healthcare: A Cross-Sectional Study on ClinicalTrials.gov.

Int J Environ Res Public Health. 2022-10-21

[10]
Nebulized corticosteroids systemic corticosteroids for patients with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis comparing the benefits and harms reported by observational studies and randomized controlled trials.

Front Pharmacol. 2022-10-5

本文引用的文献

[1]
Value of artificial intelligence model based on unenhanced computed tomography of urinary tract for preoperative prediction of calcium oxalate monohydrate stones .

Ann Transl Med. 2021-7

[2]
Predicting Antituberculosis Drug-Induced Liver Injury Using an Interpretable Machine Learning Method: Model Development and Validation Study.

JMIR Med Inform. 2021-7-20

[3]
Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database.

Front Oncol. 2021-5-31

[4]
Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure.

Int J Med Sci. 2021

[5]
Predicting 30-days mortality for MIMIC-III patients with sepsis-3: a machine learning approach using XGboost.

J Transl Med. 2020-12-7

[6]
Risk factors and associated outcomes of hospital readmission in COPD: A systematic review.

Respir Med. 2020-11

[7]
Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease.

Ther Adv Respir Dis. 2020

[8]
Early readmission and its predictors among patients treated for acute exacerbations of chronic obstructive respiratory disease in Ethiopia: A prospective cohort study.

PLoS One. 2020-10-6

[9]
Redundant medication use during acute exacerbation of chronic obstructive pulmonary disease in hospitalized patients.

Int J Clin Pharm. 2020-10

[10]
The COPD-readmission (CORE) score: A novel prediction model for one-year chronic obstructive pulmonary disease readmissions.

J Formos Med Assoc. 2021-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索